Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-22-018993)

Filing Details

Accession Number:: 0001437749-22-018993
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-04 21:34:38
Reporting Period:: 2022-08-02

Accepted Time:: 2022-08-04 21:34:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401667	Puma Biotechnology Inc.	PBYI	Pharmaceutical Preparations (2834)	770683487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1758507	F Maximo Nougues	C/O Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles CA 90024	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-08-02	161	$2.89	111,577	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.